In lung cancer, STK11 knockdown has been reported to increase cell motility and invasiveness and influence many epithelial–mesenchymal transition (EMT) pathway marker proteins, such as ZEB1 and E-cadherin [25]. The gene discussed is CDH1; the disease is lung carcinoma.